TECHNOLOGY
LEADERSHIP
ADVISORS
BOARD
CONTACT
TECHNOLOGY
ECM Biosurgery is focused on the application of a proprietary technology platform, Designer Collagens, to develop a portfolio of products to address surgical needs in human and animal health.
ECM Biosurgery portfolio of biosurgery products will address a $2-3 billion market potential across General, Plastic & Reconstructive, Cardiovascular, and Gynecology surgery.
LEADERSHIP
David McQuillan, PhD
CEO
David is an expert in medical devices and regenerative medicine (product development, business development, IP, corporate strategy).
Magnus Hook, PhD
CSO
Magnus is an internationally recognized expert in bacterial pathogenesis and ECM biology. He has published more than 200 scientific papers and is inventor on more than 30 patents.
Brooke Russell, PhD
Vice President
Brooke is trained in medical sciences and is
Canaan Whitfield, DVM
Vice President, Animal Health
Canaan manages an active research program in equine surgical practice, wound healing, and infectious disease.
ADVISORS
Noah Cohen, PhD, MPH, VMD
Associate Department Head and Professor Large Animal Internal Medicine, Texas A&M University
Greg Schultz, PhD
Professor of Obstetrics and Gynecology, University of Florida
Charles Butler, MD, FACS
Charles B. Barker Chair in Surgery, Department of Plastic Surgery, Division of Surgery, MD Anderson Cancer Center
Elizabeth Cosgriff-Hernandez, PhD
Professor of Biomedical Engineering, University of Texas
Eddy J Rogers, Counsel
BOARD OF DIRECTORS
Magnus Hook, PhD
Chairman
Larry Lawson
David McQuillan, PhD
Joseph Patti, Ph.D.
Jed Rogers, DVM
John Untereker